Business & Entrepreneurship

New research by Hannah Birnbaum at Olin Business School finds that one reason why more people in advantaged groups — particularly men and white people — do not engage in acts of allyship is because they underestimate how their actions will be appreciated by members of disadvantaged groups.

As set forth in our strategic vision, WashU is preparing and challenging everyone in our university community — students, faculty and staff — to step forward to serve, in ways large or small, to have a positive impact on our region, nation and world.

New Olin Business School research suggests those touched by the sometimes devastating effects of the COVID-19 pandemic are now more likely to recognize sources of inequality and, in turn, advocate for greater equality in the United States.

New research from Olin Business School has identified one reason why some first-time producers struggle to repeat their initial creative productions while others go on to continually produce creative works.

Every day we make thousands of decisions, from the small – what to eat? what to wear? – to the potentially life-changing choices involving our health or financial future. Olin Business School consumer behavior psychologist Hannah Perfecto does her research at the juncture of judgment and decision-making and has learned none of it has to be so hard.

It is hard to imagine a scenario where the current standoff between baseball owners and players would lead to lost games in 2022, according to Patrick Rishe, a leading sports business expert at Olin Business School.

Three business scientists, including two at Olin Business School, pored over 20 seasons of Major League Baseball hit-batsman statistics to reach some intriguing data and conclusions with implications off the field and in the office.

Hybrid work may be the future for many organizations post-pandemic, but there will be significant challenges to overcome — perhaps even more so than traditional in-person offices and fully remote work environments, say Olin Business School researchers.

Pharmaceutical and biotechnology companies topped the 2021 RQ Top 50 list of the most innovative U.S. companies. The annual ranking identifies the smartest R&D spenders – those companies that both spend big (at least $100 million in R&D) and provide the greatest returns to shareholders from that investment.

When faced with a cutting-edge technological idea, business leaders who approach the idea in more concrete “how” terms — rather than in abstract “why” terms — are less likely to be deterred by its novelty and more likely to recognize its utility, which increases their propensity to invest in the idea, according to new research from the Olin Business School.